Orlistat in the treatment of NASH: a case series

Harrison, Stephen A.; Ramrakhiani, Sanjay; Brunt, Elizabeth M.; Anbari, Maan A.; Cortese, Cherise; Bacon, Bruce R.
April 2003
American Journal of Gastroenterology;Apr2003, Vol. 98 Issue 4, p926
Academic Journal
Nonalcoholic steatohepatitis is now recognized as a common chronic liver disorder. Up to 16% of affected patients may progress to cirrhosis. The incidence and prevalence of this disease are noted to be increasing, in parallel with the nationwide increase in obesity and diabetes. Treatment options for these patients remain quite limited, however. Weight reduction has been advocated, but there are little data to support this practice, as most patients are unable to comply with the proper dietary modifications. We report three obese patients with biopsy-proven nonalcoholic steatohepatitis treated for 6–12 months with a weight reduction medication, orlistat, who lost between 22–42 lb, and had significant clinical and histopathological improvement on follow-up.


Related Articles

  • Liver disease and anaesthesia.  // British Medical Journal;5/27/1978, Vol. 1 Issue 6124, p6 

    Examines the effects of anesthesia to patients with liver diseases. Significance of assessing liver metabolic activity in determining the extent of liver damage; Discussions on operative risks; Importance of assessing renal functions in surgical management.

  • Lumiracoxib.  // Reactions Weekly;7/6/2013, Issue 1460, p29 

    The article presents a case study of a 83-year-old woman with the history of osteoporosis, who developed cholestatic liver injury while treating with lumiracoxib.

  • Fulminant hepatitis a in patients with chronic liver disease- the importance of immunization revisited. Jalil, Sajid; Gurakar, Ahmet O; Bader, Ted F; Wright, Harlan I; Nour, Bakr M; Sebastian, Anthony // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS138 

    An abstract of the article "Fulminant Hepatitis A in Patients With Chronic Liver Disease- The Importance of Immunization Revisited," by Sajid Jalil, Ahmet O. Gurakar, Ted F. Bader, Harlan I. Wright, Bakr M. Nour, and Anthony Sebastian is presented.

  • Q Fever Hepatitis. Dupont, H.L.; Hornick, R.B.; Levin, H.S.; Rapoport, M.I.; Woodward, T.E. // Annals of Internal Medicine;Feb71, Vol. 74 Issue 2, p198 

    Discusses a study that appraised hepatic involvement in three individuals with Q fever. Description of Q fever; Evolution of the pulmonary infiltrate over a six-day period; Medical profile of the patients; Histopathologic changes in the liver biopsy specimens taken from two volunteers with...

  • Live Disease a Possible Predictor of Stroke.  // Asian Journal of Epidemiology;2011, Vol. 4 Issue 1, p31 

    The article reports that according to the study by researchers at St. Michael's Hospital and the London Health Sciences Centre, people suffering from fatty liver disease are more likely to suffer a stroke than those without fatty liver.

  • Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.  // British Medical Journal;5/28/1977, Vol. 1 Issue 6073, p1384 

    Presents a study that measured the plasma half lives of antipyrine, paracetamol and lignocaine in 23 patients with stable chronic liver diseases. Patients and methods; Results; Conclusions.

  • Prescreening versus empirical immunization for hepatitis A in patients with chronic liver disease: a prospective cost analysis. Duncan, Marten; Hirota, William K.; Tsuchida, Amy // American Journal of Gastroenterology;Jul2002, Vol. 97 Issue 7, p1792 

    OBJECTIVES:There are few prospective studies estimating the prevalence of hepatitis A in chronic liver disease patients. Furthermore, there are minimal cost-comparative data as to whether or not screening for hepatitis A exposure before immunization is an effective fiscal strategy. The...

  • Nonalcoholic Fatty Liver Disease. Marchesini, Giulio; Brizi, Mara; Bianchi, Giampaolo; Tomassetti, Sara; Bugianesi, Elisabetta; Lenzi, Marco; McCullough, Arthur J.; Natale, Stefania; Forlani, Gabriele; Melchionda, Nazario // Diabetes;Aug2001, Vol. 50 Issue 8, p1844 

    Examines the insulin sensitivity of patients with nonalcoholic fatty liver disease. Analysis of the normal glucose tolerance; Reduction of glucose disposal during euglycemic clamping; Decrease in postabsorptive hepatic glucose production.

  • A 64 year old woman with knee pain: case outcome. Tugwell, Peter; O'Connor, Annette M.; Santesso, Nancy A. // BMJ: British Medical Journal (International Edition);7/3/2004, Vol. 329 Issue 7456, p38 

    Discusses the case of a 64-year-old woman who visited her doctor after reading a newspaper article about the risks of chronic use of paracetamol with alcohol intake. Woman's need for pain relief and her reluctance to give up alcohol; Patient's decision that the small increase in her risk in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics